CROWN ELECTROKINETICS CORP (CRKN)       0.2871  +0.02 (+8.38%)

0.2871  +0.02 (+8.38%)

US2283392064 - Common Stock - After market: 0.29 +0 (+1.01%)


Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CRKN. CRKN was compared to 122 industry peers in the Chemicals industry. Both the profitability and financial health of CRKN have multiple concerns. CRKN is valued expensive and it does not seem to be growing.

Note: CRKN has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of CRKN is 3.00. This is a low score and indicates issues in the health and profitability of CRKN.

VS Industry

Valuation

Valuation Rating

1

With a price book ratio of 2.12, CRKN is valued correctly.
Compared to an average industry price book ratio of 2.11, CRKN is valued in line with its industry peers.

The Price/Earnings Ratio is negative for CRKN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CRKN. No positive earnings are expected for the next year.
VS Industry

Price/Book (2.12) VS Industry: 48% outperformed.

812.13
0.03

Growth

Growth Rating

2

CRKN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.06%, which is quite impressive.
CRKN is expected to show a very negative growth in Earnings Per Share. In the coming 5 years, the EPS will decrease by -29.47% yearly.

The Revenue for CRKN has decreased by -100.00% in the past year. This is quite bad

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 58.06% -113.33% -29.47% N/A N/A
RevenueN/A N/A -100% N/A N/A N/A N/A

Health

Health Rating

2

The Debt to Equity ratio of CRKN is way better than the industry averages. CRKN has a better rating than 88% of its industry peers.
A Current Ratio of 0.45 indicates that CRKN may have some problems paying its short term obligations.
Compared to an average industry Current Ratio of 2.07, CRKN is worse placed to pay its short term obligations than its industry peers. 95% of its industry peers have a better Current Ratio.
A Quick Ratio of 0.45 indicates that CRKN may have some problems paying its short term obligations.

Compared to an average industry Quick Ratio of 1.33, CRKN is worse placed to pay its short term obligations than its industry peers. 95% of its industry peers have a better Quick Ratio.
CRKN has an Altman-Z score of -28.26. This is a bad value and indicates that CRKN is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.72, CRKN is in worse financial state than most of its industry peers. 99% of its industry peers have a better Altman-Z score.
The Piotroski-F score of CRKN is 3.00. This is a low score and indicates issues in the health and profitability of CRKN.
VS Industry

Debt/Equity (0) VS Industry: 88% outperformed.

19.13
0.00

Quick Ratio (0.45) VS Industry: 5% outperformed.

0.01
65.94

Current Ratio (0.45) VS Industry: 5% outperformed.

0.01
65.94

Altman-Z (-28.26) VS Industry: 1% outperformed.

-529.45
145.08

Dividend

Dividend Rating

0

No dividends for CRKN!.

CROWN ELECTROKINETICS CORP0.2871

NASDAQ:CRKN (1/27/2023, 7:01:15 PM)+0.02 (+8.38%)

After market: 0.29 +0 (+1.01%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) 11-10 2022-11-10/amc Earnings (Next) N/A N/A
Inst Owners 13.26% Inst Owner Change -4.69%
Ins Owners N/A Ins Owner Change 0%
Market Cap 5.82M Analysts 80
Price Target 11.22 (3808.05%)

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -350.14%
Min EPS beat(2) -737.25% Max EPS beat(2) 36.97%
EPS beat(4) 1 Avg EPS beat(4) -350.86%
Min EPS beat(4) -737.25% Max EPS beat(4) 36.97%
Revenue beat(2) N/A Avg Revenue beat(2) -100%
Min Revenue beat(2) -100% Max Revenue beat(2) -100%
Revenue beat(4) N/A Avg Revenue beat(4) -100%
Min Revenue beat(4) -100% Max Revenue beat(4) -100%
PT rev (1m) 0% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) N/A
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.12
P/tB 5.33
EV/EBITDA N/A
EPS(TTM) -2.85 EY N/A
EPS(NY) -0.9 Fwd EY N/A
FCF(TTM) -0.59 FCFY N/A
OCF(TTM) -0.56 OCFY N/A
SpS N/A BVpS 0.14
TBVpS 0.05 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM N/A
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 3 Asset Turnover N/A

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.24%
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z -28.26
F-Score 3 WACC 9.76%
ROIC/WACC N/A Cap/Depr(3y) 603.19%
Cap/Depr(5y) 381.92% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 58.06% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 54.73%
EPS Next Y -113.33% EPS Next 2Y -29.47%
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y -100% Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y 5.41% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year 25.46%
EBIT Next 3Y N/A EBIT Next 5Y N/A
FCF growth 1Y -319.61% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -302.48%
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA